SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Young Eun Chon, Kyu Sik Jung, Seung Up Kim, Jun Yong Park, Young Nyun Park, Do Young Kim, Sang Hoon Ahn, Chae Yoon Chon, Hye Won Lee, Yehyun Park, Kwang-Hyub Han, Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population, Liver International, 2014, 34, 1
  2. 2
    Hiromi Kan, Yuki Kimura, Hideyuki Hyogo, Takayuki Fukuhara, Hatsue Fujino, Noriaki Naeshiro, Yohji Honda, Tomokazu Kawaoka, Masataka Tsuge, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Hiroshi Aikata, Hidenori Ochi, Koji Arihiro, Kazuaki Chayama, Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease, Hepatology Research, 2014, 44, 8
  3. 3
    Manoj Kumar, Archana Rastogi, Tarandeep Singh, Chhagan Behari, Ekta Gupta, Hitendra Garg, Ramesh Kumar, Vikram Bhatia, Shiv K Sarin, Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: Does etiology affect performance?, Journal of Gastroenterology and Hepatology, 2013, 28, 7
  4. 4
    C.P.M.S. Oliveira, C.R. Kappel, E.R. Siqueira, V.M.R. Lima, J.T. Stefano, M.T. Michalczuk, S.S. Marini, H.V. Barbeiro, F.G. Soriano, F.J. Carrilho, L.M.M.B. Pereira, M.R. Alvares-da-Silva, Effects of Hepatitis C virus on cardiovascular risk in infected patients: A comparative study, International Journal of Cardiology, 2013, 164, 2, 221

    CrossRef

  5. 5
    Harry Yoon, Jeong Guil Lee, Jeong Hwan Yoo, Myung Su Son, Dae Young Kim, Seong Gyu Hwang, Kyu Sung Rim, Effects of Metabolic Syndrome on Fibrosis in Chronic Viral Hepatitis, Gut and Liver, 2013, 7, 4, 469

    CrossRef

  6. 6
    Victoria A. Sublette, Mark W. Douglas, Kirsten McCaffery, Jacob George, Kathryn Nicholson Perry, Psychological, lifestyle and social predictors of hepatitis C treatment response: a systematic review, Liver International, 2013, 33, 6
  7. 7
    Jing-Houng Wang, Chao-Hung Hung, Fang-Ying Kuo, Hock-Liew Eng, Chien-Hung Chen, Chun-Mo Lee, Sheng-Nan Lu, Tsung-Hui Hu, Ultrasonographic Quantification of Hepatic–Renal Echogenicity Difference in Hepatic Steatosis Diagnosis, Digestive Diseases and Sciences, 2013, 58, 10, 2993

    CrossRef

  8. 8
    Masato Yoneda, Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases, Hepatology Research, 2013, 43, 11
  9. 9
    Robert P. Myers, Aaron Pollett, Richard Kirsch, Gilles Pomier-Layrargues, Melanie Beaton, Mark Levstik, Andres Duarte-Rojo, David Wong, Pam Crotty, Magdy Elkashab, Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography, Liver International, 2012, 32, 6
  10. 10
    Feyza Gunduz, Fatma M Aboulnasr, Partha K Chandra, Sidhartha Hazari, Bret Poat, Darren P Baker, Luis A Balart, Srikanta Dash, Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture, Virology Journal, 2012, 9, 1, 143

    CrossRef

  11. 11
    J. Rowell, A. J. Thompson, J. R. Guyton, X. Q. Lao, J. G. McHutchison, J. J. McCarthy, K. Patel, Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis, Hepatology International, 2012, 6, 2, 475

    CrossRef

  12. 12
    L. Restivo, R. Zampino, B. Guerrera, L. Ruggiero, L. E. Adinolfi, Steatosis is the predictor of relapse in HCV genotype 3- but not 2-infected patients treated with 12 weeks of pegylated interferon-α-2a plus ribavirin and RVR, Journal of Viral Hepatitis, 2012, 19, 5
  13. 13
    Naga Chalasani, Zobair Younossi, Joel E Lavine, Anna Mae Diehl, Elizabeth M Brunt, Kenneth Cusi, Michael Charlton, Arun J Sanyal, The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, The American Journal of Gastroenterology, 2012, 107, 6, 811

    CrossRef

  14. 14
    Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal, The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology, Gastroenterology, 2012, 142, 7, 1592

    CrossRef

  15. You have free access to this content15
    Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal, The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, Hepatology, 2012, 55, 6
  16. 16
    Maria Guido, Alessandra Mangia, Gavino Faa, Chronic viral hepatitis: The histology report, Digestive and Liver Disease, 2011, 43, S331

    CrossRef

  17. 17
    I-Cheng Lee, Yi-Hsiang Huang, Che-Chang Chan, Teh-Ia Huo, Chi-Jen Chu, Chiung-Ru Lai, Pui-Ching Lee, Chien-Wei Su, Jaw-Ching Wu, Han-Chieh Lin, Shou-Dong Lee, Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B, Clinical Nutrition, 2011, 30, 5, 647

    CrossRef

  18. 18
    Keyur Patel, Alexander J Thompson, Wan-Long Chuang, Chuan-Mo Lee, Chen-Yuan Peng, Ganesananthan Shanmuganathan, Satawat Thongsawat, Tawesak Tanwandee, Varocha Mahachai, Chutima Pramoolsinsap, Mong Cho, Kwang Hyup Han, Samir R Shah, Graham R Foster, Paul J Clark, Erik Pulkstenis, G. Mani Subramanian, John G McHutchison, Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients, Journal of Gastroenterology and Hepatology, 2011, 26, 7
  19. 19
    Samir R. Shah, Keyur Patel, Patrick Marcellin, Graham R. Foster, Michael Manns, Shyam Kottilil, Letha Healey, Erik Pulkstenis, G. Mani Subramanian, John G. McHutchison, Mark S. Sulkowski, Stefan Zeuzem, David R. Nelson, Steatosis Is an Independent Predictor of Relapse Following Rapid Virologic Response in Patients With HCV Genotype 3, Clinical Gastroenterology and Hepatology, 2011, 9, 8, 688

    CrossRef

  20. 20
    Birke Bartosch, Hepatitis B and C Viruses and Hepatocellular Carcinoma, Viruses, 2010, 2, 8, 1504

    CrossRef

  21. 21
    K. Rajender Reddy, Mitchell L. Shiffman, Maribel Rodriguez–Torres, Hugo Cheinquer, Djamal Abdurakhmanov, Igor Bakulin, Viacheslav Morozov, Giovanni Faria Silva, Natalia Geyvandova, Carol Stanciu, Michael Rabbia, Michael McKenna, James A. Thommes, Stephen A. Harrison, Induction Pegylated Interferon Alfa-2a and High Dose Ribavirin Do Not Increase SVR in Heavy Patients With HCV Genotype 1 and High Viral Loads, Gastroenterology, 2010, 139, 6, 1972

    CrossRef

  22. 22
    Paul Targett-Adams, Steeve Boulant, Mark W. Douglas, John McLauchlan, Lipid Metabolism and HCV Infection, Viruses, 2010, 2, 5, 1195

    CrossRef

  23. 23
    François Bailly, Si Nafa Si Ahmed, Pierre Pradat, Christian Trepo, Management of nonresponsive hepatitis C, Expert Review of Anti-infective Therapy, 2010, 8, 4, 379

    CrossRef

  24. 24
    Paul Lamb, Stephen Harrison, Metabolic Syndrome and HCV: Where Do We Stand in 2010?, Current Hepatitis Reports, 2010, 9, 3, 133

    CrossRef